ArticleArchives of endocrinology and metabolism2018
Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer.
Debora L S Danilovic et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it